Special Report

A 5-part video series tackling updates and unmet needs in bronchiectasis in the wake of the August 2025 approval of bronchiectasis.

Leading experts in nephrology react to how the FDA approval of pegcetacoplan (Empaveli) shifts treatment discussions for patients with C3 glomerulopathy.

A trio of advanced heart failure specialists discusses how the approval of finerenone and other recent updates impact management for heart failure with mildly reduced or preserved ejection fraction.

A trio of experts in pulmonology discuss the role of monoclonal antibodies in the management of chronic obstructive pulmonary disease following the FDA approval of mepolizumab (Nucala).

A 6-part video series tackling updates and unmet needs in scalp PsO in the wake of the May 2025 approval of roflumilast.

A 3-part video series highlighting the connection between immune-mediated inflammatory diseases in GI and dermatology.

A multipart video series featuring perspectives from leading experts in dermatology on the role of lebrikizumab (Ebglyss) in patients with atopic dermatitis and skin of color.

A 3-part video series tackling updates and unmet needs in RSV in the wake of the clesrovimab approval in June 2025.

A 4-part video series tackling updates and unmet needs in ATTR-CM in the wake of the vutrisiran approval in March 2025.

Experts discuss new guidance from the US Multi-Society Task Force on Colorectal Cancer (USMSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy, providing clinical recommendations to address challenges related to bowel preparation for colonoscopy, focusing specifically on outpatients at low risk for inadequate bowel preparation.

An expert panel examining updates and unmet needs in the management of metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD).

In this 5-part discussion, a trio of experts break down the latest updates in pediatric food allergy and anaphylaxis management on the heels of the AAAAI 2025 annual meeting and a recent approval for needle-free epinephrine.

Steven Fein, MD, discusses clinically relevant updates in hematology from the American Society of Hematology meeting and the rest of 2024.

A 3-part discussion on a recent scientific statement on the role and utility of lipoprotein apheresis from the American Heart Association, hosted by document chair Laurence Sperling, MD, and vice-chair Eugenia Gianos, MD.

A multipart discussion, filmed immediately following the seladelpar decision, examining how recent advances have changed discussions in the managament of primary biliary cholangitis, with expert perspectives from Nancy Reau, MD, Palak Trivedi, MD, PhD, and Gideon Hirschfield, PhD, MB BChir.

In recognition of Hepatitis Awareness Month and Hepatitis Testing Day, this HCPLive Special Report spotlights a conversation between subject matter experts on updates and unmet needs in the management of hepatitis B virus in 2024.

Ophthalmologists Veeral Sheth, MD, and David Lally, MD provide an overview of geographic atrophy, an advanced stage of dry age-related macular degeneration, and describe the unfolding treatment landscape for the disease.

Expert advanced practice providers in the field of dermatology are sharing their experience and knowledge in treating patients with hidradenitis suppurativa. They are discussing the impact of this chronic disease on the quality of life of patients, as well as new insights in the pathophysiology of hidradenitis suppurativa guiding the development of novel treatments.

Dermatologists Drs Neal Bhatia and Dr Leon Kircik discuss topical treatments and how recent approval of a novel topical PDE4 inhibitor is likely to impact the treatment landscape of plaque psoriasis.

David P. Hudesman, shares insight on long-term extension data and clinical implications from ACG 2022 on the use of ustekinumab for the management of ulcerative colitis.